Quantcast

Latest Interleukin Genetics Inc. Stories

2011-08-12 07:39:00

WALTHAM, Mass., Aug. 12, 2011 /PRNewswire/ -- Interleukin Genetics, Inc. (OTCQB: ILIU) today announced financial and operational results for the second quarter ended June 30, 2011. Total revenue for the three months ended June 30, 2011 was $0.8 million compared to $0.6 million for the same period in the prior year. The increase was attributable to greater genetic test revenue. Research and development expenses were $0.4 million for the three months ended June 30, 2011, compared to $0.3...

2011-08-11 07:30:00

WALTHAM, Mass., Aug. 11, 2011 /PRNewswire/ -- Interleukin Genetics, Inc. (OTCQB: ILIU) announced today that CEO Lewis H. Bender will present at the Wedbush Securities Life Sciences Management Access Conference at the Le Parker Meridien Hotel, 119 West 56th Street in New York City. The presentation is scheduled for Wednesday, Aug. 17 at 3:35 p.m. (EDT) in the Lorica Room, located on the second floor. Interleukin's management team will be available for one-on-one meetings with investors...

2011-08-04 15:03:00

WALTHAM, Mass., Aug. 4, 2011 /PRNewswire/ -- Interleukin Genetics, Inc. (OTCQB: ILIU) announced today that it will host a conference call and Webcast on Friday, August 12 at 9:30 a.m. EDT to discuss the Company's second quarter results. To access the live call, dial 877-324-1976 (domestic) or 631-291-4550 (international). The live Webcast and replay access of the teleconference will be available on the Investors section of Interleukin Genetics, Inc.'s Website at http://www.ilgenetics.com....

2011-05-25 06:30:00

MADRID and WALTHAM, Mass., May 25, 2011 /PRNewswire/ -- Interleukin Genetics, Inc. (OTCQB: ILIU) and Labec Pharma SA today announced that USP Hospitales now offers the innovative Heart Health Genetic Test, developed by Interleukin Genetics, at San Jose, USP Hospitales, the flagship hospital in Madrid, and will soon make it available throughout their hospital network. The test identifies single nucleotide variations in two Interleukin-1 (IL-1) genes that lead to a greater predisposition of...

2011-05-12 15:20:00

WALTHAM, Mass., May 12, 2011 /PRNewswire/ -- Interleukin Genetics, Inc. (OTCQB: ILIU) today announced financial and operational results for the first quarter ended March 31, 2011. Total revenue for the three months ended March 31, 2011 was $0.7 million compared to $0.4 million for the same period in the prior year. The increase was attributable to greater genetic test revenue. Research and development expenses were $0.3 million for the three months ended March 31, 2011, compared to $0.4...

2011-05-10 06:30:00

WALTHAM, Mass. and GIG HARBOR, Wash., May 10, 2011 /PRNewswire/ -- Interleukin Genetics, Inc. (OTCQB: ILIU) and Metagenics, Inc. today announced that they have entered into a research collaboration to identify predictive biomarkers combinations for use with Metagenics Compound Meta-060, which is a proprietary and patented formulation of tetrahydro iso-alpha acids derived from hops, in development for weight management. A key aim of the collaboration is to investigate if genetic variations...

2011-05-09 06:30:00

WALTHAM, Mass., May 9, 2011 /PRNewswire/ -- Interleukin Genetics, Inc. (OTCQB: ILIU) today announced the launch of a comprehensive suite of new free and subscriber-based weight loss web-based tools on the Inherent Health website (www.inherenthealth.com). The new tools help to optimize diet and exercise management for users of the Inherent Health® Weight Management Genetic Test. These tools provide customers with a convenient, informative and fun way to manage diet and...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related